Floatz logo

Calcium folinate pentahydrate

Renal Cell Carcinoma

Neonc Technologies, Inc.Small moleculePhase 1/2Active
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
65/ 100

Competitive context

144 Active assets in the Renal Cell Carcinoma cohort.

Asset / SponsorPhaseRating
su011248
Peking University Cancer Hospital & Institute
Phase 4BB
Nivolumab
Fred Hutchinson Cancer Center
Phase 4BB
Alpha-Interferon
Fuzhou General Hospital
Phase 3BB
Everolimus
Merck Sharp & Dohme LLC
Phase 4BB
Pembrolizumab
City of Hope Medical Center
Phase 4BB

View all 50 →

Same molecule, other indications

Calcium folinate pentahydrate is also rated in:

Advanced KRAS Positive Metastatic Colorectal CancerDormant
BBB
Indicative ·
78 / 100
View asset →
Recurrent Pancreatic CarcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
Stage IV Colon CancerDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →